Overview of Techniques and Description of Established Processes

[1]  D. Crommelin,et al.  Gamma-irradiation of liposomes composed of saturated phospholipids: effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes. , 1996, Biochimica et biophysica acta.

[2]  Floyd,et al.  Top ten considerations in the development of parenteral emulsions. , 1999, Pharmaceutical science & technology today.

[3]  Jack Legrand,et al.  Analysis of a new type of high pressure homogeniser. Part B. study of droplet break-up and recoalescence phenomena , 2004 .

[4]  S. Inghelbrecht,et al.  Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design. , 2011, Journal of pharmaceutical sciences.

[5]  Gerrit Borchard,et al.  Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars. , 2015, Nanomedicine.

[6]  Xiaolin Tang,et al.  Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice , 2004, Pharmaceutical Research.

[7]  Michael Juhnke,et al.  Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach , 2010 .

[8]  J. M. Shaw,et al.  Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs , 1996, Pharmaceutical Research.

[9]  Indrajit Ghosh,et al.  Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  Ludo Froyen,et al.  Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  S. Stainmesse,et al.  Freeze-drying of nanoparticles: formulation, process and storage considerations. , 2006, Advanced drug delivery reviews.

[12]  W. Peukert,et al.  Impact of stressing conditions and polymer–surfactant interactions on product characteristics of organic nanoparticles produced by media milling , 2016 .

[13]  Lode Vereeck,et al.  Future of nanomedicine: obstacles and remedies. , 2011, Nanomedicine.

[14]  P. Gassmann,et al.  Hydrosols : alternatives for the parenteral application of poorly water soluble drugs , 1994 .

[15]  J. Saurina,et al.  An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review. , 2012, Analytica chimica acta.

[16]  Eva Roblegg,et al.  Nano-extrusion: a One-Step Process for Manufacturing of Solid Nanoparticle Formulations Directly from the Liquid Phase , 2013, AAPS PharmSciTech.

[17]  Arno Kwade.  Mill selection and process optimization using a physical grinding model , 2004 .

[18]  T. Kuiken.  Nanomedicine and ethics: is there anything new or unique? , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[19]  F. Szoka,et al.  Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. , 1979, Biochimica et biophysica acta.

[20]  Vanessa Sainz,et al.  Regulatory aspects on nanomedicines. , 2015, Biochemical and biophysical research communications.

[21]  Andreas Wagner,et al.  Liposome Technology for Industrial Purposes , 2010, Journal of drug delivery.

[22]  A. C. Eissens,et al.  Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  M. Brandl,et al.  Steam sterilisation of vesicular phospholipid gels. , 2001, International journal of pharmaceutics.

[24]  Amarnath Sharma,et al.  Liposomes in drug delivery: Progress and limitations , 1997 .

[25]  G. Van den Mooter,et al.  Review: physical chemistry of solid dispersions , 2009 .

[26]  G. Van den Mooter,et al.  Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Z. A. Worku,et al.  Oral formulation strategies to improve solubility of poorly water-soluble drugs , 2011, Expert opinion on drug delivery.

[28]  Carmen Popescu,et al.  Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study , 2008, Pharmaceutical Research.

[29]  D. Lasič,et al.  Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs , 1991 .

[30]  P. Wehrlé,et al.  Sterile filtration of liposomes: Retention of encapsulated carboxyfluorescein , 1995 .

[31]  M. C. Popescu,et al.  Unusual lipid structures selectively reduce the toxicity of amphotericin B. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Rainer H Müller,et al.  Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  A. Kwade,et al.  Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  A. Kwade,et al.  Feinstzerkleinerung organischer Partikeln in Rührwerkskugelmühlen: Bestimmung günstiger Formulierungen und Prozessparameter , 2016 .

[35]  Jun Li,et al.  Preparation and characterization of intravenously injectable nimodipine nanosuspension. , 2008, International journal of pharmaceutics.

[36]  Zhiqiang Yan,et al.  Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route. , 2015, Current pharmaceutical design.

[37]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Dandan Han,et al.  An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[39]  E. Alphandéry,et al.  Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects , 2015, Expert review of anticancer therapy.

[40]  L. Fuchs,et al.  Visual observations and acoustic measurements of cavitation in an experimental model of a high-pressure homogenizer , 2010 .

[41]  Ikram Ullah Khan,et al.  Production of nanoparticle drug delivery systems with microfluidics tools , 2015, Expert opinion on drug delivery.

[42]  Indu Pal Kaur,et al.  Issues and concerns in nanotech product development and its commercialization. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[43]  J. Remon,et al.  An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. , 2001, International journal of pharmaceutics.

[44]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[45]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[46]  B. Mukherjee,et al.  Toxicological Concerns of Engineered Nanosize Drug Delivery Systems , 2016, American journal of therapeutics.

[47]  Y. Barenholz,et al.  Annals of the New York Academy of Sciences Nanomedicines: Addressing the Scientific and Regulatory Gap , 2022 .

[48]  ANTONIO G. SPAGNOLO,et al.  Outlining Ethical Issues in Nanotechnologies , 2009, Bioethics.

[49]  P. Walstra,et al.  Chapter 2:Emulsion Formation , 1998 .

[50]  H. Schubert,et al.  Emulsification in High‐Pressure Homogenizers , 2001 .

[51]  L. Guo.  Amphotericin B colloidal dispersion: an improved antifungal therapy. , 2001, Advanced drug delivery reviews.

[52]  R. Davé,et al.  A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves , 2013 .

[53]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[54]  Man Liu,et al.  Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization” , 2014, The AAPS Journal.

[55]  H. M. Nielsen,et al.  Stabilization of liposomes during drying , 2011, Expert opinion on drug delivery.

[56]  Jaap C. Schouten,et al.  Hydrodynamic cavitation in micro channels with channel sizes of 100 and 750 micrometers , 2012 .

[57]  Martin Brandl,et al.  Preparation of liposomes using a Mini-Lab 8.30 H high-pressure homogenizer , 1993 .

[58]  Arno Kwade,et al.  Challenges in Nanogrinding of Active Pharmaceutical Ingredients , 2014 .

[59]  A. Bangham.  Liposomes: the Babraham connection. , 1993, Chemistry and physics of lipids.

[60]  L. Froyen,et al.  Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  Rong-Kun Chang,et al.  Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. , 2013, Journal of pharmaceutical sciences.

[62]  S. Büttgenbach,et al.  High-pressure microfluidic systems (HPMS): flow and cavitation measurements in supported silicon microsystems , 2015 .

[63]  Pegi Ahlin Grabnar,et al.  The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers , 2011, Journal of microencapsulation.

[64]  Raviraj Pillai,et al.  Production and In Vitro Characterization of Solid Dosage form Incorporating Drug Nanoparticles , 2008 .

[65]  R. Duncan,et al.  Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[66]  V. Nekkanti,et al.  Development and characterization of solid oral dosage form incorporating candesartan nanoparticles , 2009, Pharmaceutical development and technology.

[67]  Wean Sin Cheow,et al.  Towards sustainability: new approaches to nano-drug preparation. , 2013, Current pharmaceutical design.

[68]  R. Naeff.  Feasibility of topical liposome drugs produced on an industrial scale , 1996 .

[69]  Wei He,et al.  Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution , 2013, International journal of nanomedicine.

[70]  J. Lovrić,et al.  Nanotherapeutics in the EU: an overview on current state and future directions , 2014, International journal of nanomedicine.

[71]  Peter D Brown,et al.  Nanomedicine: a pharma perspective. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[72]  H W Frijlink,et al.  A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[73]  R. Müller,et al.  Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). , 2011, International journal of pharmaceutics.

[74]  H. Ohshima,et al.  Physicochemical Characterization of Parenteral Lipid Emulsion: Influence of Cosurfactants on Flocculation and Coalescence , 1995, Pharmaceutical Research.

[75]  S M Gruner,et al.  Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. , 1998, Biochimica et biophysica acta.

[76]  J. Adler-Moore,et al.  Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin B , 1993 .

[77]  E. Korn,et al.  Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.

[78]  T. Merdan,et al.  Recent advances in intravenous delivery of poorly water-soluble compounds , 2009, Expert opinion on drug delivery.

[79]  Michael Juhnke,et al.  Generation of wear during the production of drug nanosuspensions by wet media milling. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[80]  L. Lévy,et al.  Delivering nanomedicines to patients: a practical guide. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[81]  H. Katinger,et al.  GMP Production of Liposomes—A New Industrial Approach , 2006, Journal of liposome research.

[82]  A. Elaissari,et al.  Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison. , 2011, Advances in colloid and interface science.

[83]  Martin G Pomper,et al.  State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[84]  A. Bangham,et al.  NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.

[85]  T. Schneider,et al.  Large-Scale Production of Liposomes of Defined size by a New Continuous High Pressure Extrusion Device , 1994 .

[86]  S. Alaei,et al.  Spray drying of cefixime nanosuspension to form stabilized and fast dissolving powder , 2016 .

[87]  Arno Kwade,et al.  Breaking characteristics of different materials and their effect on stress intensity and stress number in stirred media mills , 2002 .

[88]  N. Desai,et al.  Characterization and in vitro/in vivo dissolution of nab-paclitaxel nanoparticles , 2008 .

[89]  Rainer H Müller,et al.  Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[90]  S. Inghelbrecht,et al.  Freeze-drying of nanosuspensions, part 3: investigation of factors compromising storage stability of highly concentrated drug nanosuspensions. , 2012, Journal of pharmaceutical sciences.

[91]  Marina A. Dobrovolskaia,et al.  Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[92]  Arno Kwade,et al.  A Stressing Model for the Description and Optimization of Grinding Processes , 2003 .

[93]  S Kumar,et al.  Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. , 2011, International journal of pharmaceutics.

[94]  H. Hauser.  The effect of ultrasonic irradiation on the chemical structure of egg lecithin. , 1971, Biochemical and biophysical research communications.

[95]  R. Duncan,et al.  Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines. , 2013, Nanomedicine.

[96]  Matthias Wacker,et al.  Nanocarriers for intravenous injection--the long hard road to the market. , 2013, International journal of pharmaceutics.

[97]  J. Remon,et al.  In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen. , 2002, International journal of pharmaceutics.

[98]  P. Cullis.  Commentary: Liposomes by Accident , 2000 .

[99]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[100]  D. G. Hunter,et al.  Effect of extrusion pressure and lipid properties on the size and polydispersity of lipid vesicles. , 1998, Biophysical journal.

[101]  M. Kislalioglu,et al.  Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. , 2012, Current drug delivery.

[102]  A. Håkansson,et al.  Dynamic simulation of emulsion formation in a high pressure homogenizer , 2009 .

[103]  V. Venditto,et al.  Designer lipids for drug delivery: from heads to tails. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[104]  Ming-Ren Toh,et al.  Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing , 2013 .

[105]  R. Müller,et al.  Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals , 2014, Drug development and industrial pharmacy.

[106]  Rainer Koch,et al.  On the visualization of droplet deformation and breakup during high-pressure homogenization , 2015 .

[107]  W. Gradishar,et al.  Albumin-bound paclitaxel: a next-generation taxane , 2006, Expert opinion on pharmacotherapy.

[108]  E. Bilgili,et al.  A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. , 2012, International journal of pharmaceutics.

[109]  S. Büttgenbach,et al.  Multiple orifices in customized microsystem high-pressure emulsification: The impact of design and counter pressure on homogenization efficiency , 2014 .

[110]  D. O’hagan.  MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection , 2007, Expert review of vaccines.

[111]  I. Ghosh,et al.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.

[112]  Rishi Paliwal,et al.  Nanomedicine Scale-up Technologies: Feasibilities and Challenges , 2014, AAPS PharmSciTech.

[113]  D. Crommelin,et al.  Gamma-Irradiation of Non-Frozen, Frozen, and Freeze-Dried Liposomes , 1995, Pharmaceutical Research.

[114]  E. R. Cooper,et al.  Nanoparticles: A personal experience for formulating poorly water soluble drugs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Nakissa Sadrieh,et al.  Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. , 2009, Advanced drug delivery reviews.

[116]  S. Baumgartner,et al.  Advantages of celecoxib nanosuspension formulation and transformation into tablets. , 2009, International journal of pharmaceutics.

[117]  Christopher J. H. Porter,et al.  Tools for Early Prediction of Drug Loading in Lipid-Based Formulations , 2015, Molecular pharmaceutics.

[118]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Miquel Pons,et al.  Liposomes obtained by the ethanol injection method , 1993 .

[120]  M. Hora,et al.  The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan, , 2000 .

[121]  Hatem Fessi,et al.  Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[122]  B. Widemann,et al.  Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates , 2016, Investigational New Drugs.

[123]  Tracy K. Pettinger,et al.  Nanopharmaceuticals (part 1): products on the market , 2014, International journal of nanomedicine.

[124]  I. Ghosh,et al.  Application of spray granulation for conversion of a nanosuspension into a dry powder form. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[125]  Jan Van Humbeeck,et al.  Downscaling Drug Nanosuspension Production: Processing Aspects and Physicochemical Characterization , 2009, AAPS PharmSciTech.

[126]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[127]  R. Müller,et al.  Lutein nanocrystals as antioxidant formulation for oral and dermal delivery. , 2011, International journal of pharmaceutics.

[128]  W. Wildeboer,et al.  Study of the process of stirred ball milling of poorly water soluble organic products using factorial design , 2010 .

[129]  Arno Kwade,et al.  Wet comminution in stirred media mills — research and its practical application , 1999 .

[130]  J. King,et al.  Characterization of liposomes prepared using a microemulsifier. , 1984, Biochimica et biophysica acta.

[131]  Rainer H Müller,et al.  Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals. , 2013, International journal of pharmaceutics.

[132]  D. Crommelin,et al.  CHAPTER 7.2 – Strategies for large scale production and optimized stability of pharmaceutical liposomes developed for parenteral use , 1998 .

[133]  R. L. Cunha,et al.  High- and Low-Energy Emulsifications for Food Applications: A Focus on Process Parameters , 2013, Food Engineering Reviews.

[134]  Jan P Möschwitzer,et al.  Drug nanocrystals in the commercial pharmaceutical development process. , 2013, International journal of pharmaceutics.

[135]  Sanjay Garg,et al.  Effect of wet milling process on the solid state of indomethacin and simvastatin. , 2009, International journal of pharmaceutics.

[136]  A. Voigt,et al.  In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells. , 2010, Small.

[137]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[138]  R. Müller,et al.  Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.

[139]  M. F. Malone,et al.  Prediction of emulsion drop size distributions with population balance equation models of multiple drop breakage , 2010 .

[140]  H. Fessi,et al.  A new method for liposome preparation using a membrane contactor , 2011, Journal of liposome research.

[141]  A. Hillery.  Supramolecular lipidic drug delivery systems: From laboratory to clinic A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B , 1997 .

[142]  G. Zampighi,et al.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. , 1981, Biochemistry.

[143]  D. Crommelin,et al.  Sterilization of Liposomes by Heat Treatment , 1993, Pharmaceutical Research.

[144]  Sandip S Chavhan,et al.  Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. , 2011, Critical reviews in therapeutic drug carrier systems.

[145]  H. Schuchmann,et al.  High-pressure double stage homogenization processes: Influences of plant setup on oil droplet size , 2015 .

[146]  H. Hauser,et al.  Single bilayer vesicles prepared without sonication. Physico-chemical properties. , 1976, Biochimica et biophysica acta.

[147]  P van Hoogevest,et al.  MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. , 1995, Pharmaceutical biotechnology.

[148]  F. Rossi,et al.  Nanomedicines in the European translational process , 2015 .

[149]  G. Zografi,et al.  Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. , 2002, Journal of pharmaceutical sciences.

[150]  S. Majumdar,et al.  Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.

[151]  Patrick Couvreur,et al.  Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices. , 2014, Advanced drug delivery reviews.

[152]  L. C. Collins-Gold,et al.  Parenteral emulsions for drug delivery , 1990 .

[153]  A. Kwade,et al.  Efficiency of different dispersing devices for dispersing nanosized silica and alumina , 2011 .

[154]  Jérôme Bellettre,et al.  Analysis of a new type of high pressure homogeniser. A study of the flow pattern , 2004 .

[155]  Jörg Schwedes,et al.  Chapter 6 Wet Grinding in Stirred Media Mills , 2007 .

[156]  Gert Fricker,et al.  Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations". , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[157]  M. Descamps,et al.  Amorphization of sugar hydrates upon milling. , 2010, Carbohydrate research.

[158]  S. Inghelbrecht,et al.  Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution. , 2011, Journal of pharmaceutical sciences.

[159]  S. Amselem,et al.  A new method for preparation of phospholipid vesicles (liposomes) ‐ french press , 1979, FEBS letters.

[160]  William Wei Lim Chin,et al.  A brief literature and patent review of nanosuspensions to a final drug product. , 2014, Journal of pharmaceutical sciences.

[161]  Sanjay Garg,et al.  Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. , 2011, International journal of pharmaceutics.

[162]  I. Norton,et al.  Comparing droplet breakup for a high-pressure valve homogeniser and a Microfluidizer for the potential production of food-grade nanoemulsions , 2013 .

[163]  D. Driscoll,et al.  Lipid Injectable Emulsions: Pharmacopeial and Safety Issues , 2006, Pharmaceutical Research.

[164]  Carlos E Figueroa,et al.  Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[165]  Dong Soo Lee,et al.  Nanomedicine: Past, present and future - A global perspective. , 2015, Biochemical and biophysical research communications.

[166]  Rainer H Müller,et al.  Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[167]  B. Frisken,et al.  Studies of Vesicle Extrusion , 2000 .

[168]  J. Khinast,et al.  Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations. , 2014, International journal of pharmaceutics.

[169]  V. Torchilin,et al.  New Developments in Liposomal Drug Delivery. , 2015, Chemical reviews.

[170]  Ludo Froyen,et al.  A screening study of surface stabilization during the production of drug nanocrystals. , 2009, Journal of pharmaceutical sciences.

[171]  Diane J Burgess,et al.  Quality by Design approach to spray drying processing of crystalline nanosuspensions. , 2014, International journal of pharmaceutics.

[172]  A. Evdokiou,et al.  An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy. , 2015, Journal of materials chemistry. B.

[173]  D. Papahadjopoulos,et al.  Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. , 1967, Biochimica et biophysica acta.

[174]  Arvid Wretlind,et al.  Invited Review: Development of Fat Emulsions , 1981 .

[175]  T. E. Thompson,et al.  A possible mechanism for vesicle formation by extrusion. , 1994, Biophysical journal.

[176]  G. Gregoriadis.  The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[177]  Neil Desai,et al.  Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[178]  M. Bally,et al.  The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. , 1990, Chemistry and physics of lipids.

[179]  W. Peukert,et al.  Nanoparticle Production with Stirred-Media Mills: Opportunities and Limits , 2010 .

[180]  Gerhard Hielscher,et al.  Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. , 2006, Ultrasonics sonochemistry.

[181]  S. Baumgartner,et al.  Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. , 2006, International journal of pharmaceutics.

[182]  Y. Ogawa,et al.  Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. , 1993, Chemical & pharmaceutical bulletin.

[183]  M. Bertrand,et al.  Extrusion of small vesicles through nanochannels: a model for experiments and molecular dynamics simulations. , 2012, Physical review. E, Statistical, nonlinear, and soft matter physics.

[184]  Sia Chong Hock,et al.  A review of the current scientific and regulatory status of nanomedicines and the challenges ahead. , 2011, PDA journal of pharmaceutical science and technology.

[185]  G. Van den Mooter,et al.  Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. , 2006, International journal of pharmaceutics.

[186]  Wyatt N Vreeland,et al.  Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. , 2004, Journal of the American Chemical Society.

[187]  Kurt E. Geckeler,et al.  Polymer nanoparticles: Preparation techniques and size-control parameters , 2011 .

[188]  Raj Bawa,et al.  Regulating nanomedicine - can the FDA handle it? , 2011, Current drug delivery.

[189]  S. Mantripragada.  A lipid based depot (DepoFoam technology) for sustained release drug delivery. , 2002, Progress in lipid research.

[190]  B. Mikrut.  Case Study: Formulation of an Intravenous Fat Emulsion , 2005 .

[191]  Arno Kwade,et al.  Use of an Enhanced Stress Model for the Optimization of Wet Stirred Media Milling Processes , 2014 .

[192]  Jörg Schwedes,et al.  Stress energy distribution in different stirred media mill geometries , 2004 .

[193]  Martin Brandl,et al.  Liposome Preparation by a New High Pressure Homogenizer Gaulin Micron Lab 40 , 1990 .

[194]  Ranjita Shegokar,et al.  Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.

[195]  M. Mazzotti,et al.  Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.

[196]  Wolfgang Friess,et al.  The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[197]  Christine Vauthier,et al.  Methods for the Preparation and Manufacture of Polymeric Nanoparticles , 2009, Pharmaceutical Research.

[198]  Patrick Augustijns,et al.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.